FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Leiter's Compounding | 079215020 | 70360-077 | 70360-077-35 | Moxifloxacin Hydrochloride | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-003 | 70360-003-35 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-001 | 70360-001-02 | Bevacizumab | 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-001 | 70360-001-60 | Bevacizumab | 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-078 | 70360-078-57 | Bupivacaine Hydrochloride | 1.25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-079 | 70360-079-59 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-079 | 70360-079-50 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-079 | 70360-079-61 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-079 | 70360-079-57 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-079 | 70360-079-51 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-079 | 70360-079-55 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-063 | 70360-063-46 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-063 | 70360-063-43 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-063 | 70360-063-39 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-012 | 70360-012-77 | Cantharidin | 7 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-007 | 70360-007-35 | Cefuroxime Sodium | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-080 | 70360-080-39 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-080 | 70360-080-38 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-080 | 70360-080-46 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-017 | 70360-017-46 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-017 | 70360-017-39 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-017 | 70360-017-38 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-058 | 70360-058-39 | Edetate Disodium | 30 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2 ug/1 mL; 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1373 | 61141-1373-5 | Glycopyrrolate | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | 61141-1326 | 61141-1326-1 | Iopamidol | 408 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1838 | 61141-1838-1 | Isoproterenol Hydrochloride | .008 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | Midazolam | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | 61141-1337 | 61141-1337-1 | Midazolam | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | Morphine Sulfate | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | 61141-4834 | 61141-4834-1 | Nitroglycerin | 100 ug/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4795 | 61141-4795-2 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 3 mg/1 mL; 3 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4813 | 61141-4813-1 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | Polidocanol | 3.5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | Polidocanol | 7 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | Polidocanol | 20 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | 61141-4538 | 61141-4538-4 | Povidone-Iodine | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1370 | 61141-1370-5 | Ropivacaine Hydrochloride | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 1.25 mg/1 mL; 2 ug/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride | 20 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4535 | 61141-4535-3 | Cefuroxime Sodium | 1 mg/.1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1374 | 61141-1374-5 | Ephedrine Sulfate | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | Ephedrine Sulfate | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | Esmolol Hydrochloride | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 10 ug/1 mL | 2019-1 | valid | 2026-11-14 | |
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Glycopyrrolate | .6 mg/3 mL | 2019-1 | source_no_ndc | 2026-11-14 |